Who’s getting the most out of their R&D engine? Pharma’s top 11, ranked

Drugmakers have myriad tools in their arsenal when looking to grow sales. They can acquire marketed drugs, raise prices or focus on growing the reach of their existing medicines. But it’s often new drug approvals that reign supreme and ultimately prove the worth of a company’s development engine.

Read the source article at Pharma News
2021-08-23 13:00:00